Ropivacaine versus Bupivacaine in bilateral maxillary nerve block for cleft lip and palate surgery

Postoperative analgesic effects of Ropivacaine versus Bupivacaine in bilateral maxillary nerve block for cleft lip and palate surgery: a double-blind randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308910451816

Enrollment

Registered

2023-08-24

Start date

2023-07-16

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Paediatrics Anaesthesia

Interventions

Group Ropivacaine

Group Bupivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Parental consent • ASA I or ASA II • Age > 3 months • Primary cleft lip and palate surgery

Exclusion criteria

Exclusion criteria: • Withdrawal from study participation • Intraoperative incident requiring intensive care unit hospitalization • Contraindication to maxillary block • Known allergy to used drugs

Design outcomes

Primary

Measure	Time frame
Postoperative pain - FLACC PAIN SCALE	—

Secondary

Measure	Time frame
Parent’s satisfaction - likert scale;Nausea and vomiting;Time to first oral liquid intake;Postoperative analgesic requirments;Time to rescue analgesia	—

Countries

Tunisia

Contacts

Public ContactSamia Ayachi

Sahloul Teaching Hospital Faculty of medecine of Sousse

samia.ayachi@gmail.com+21698322938

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026